Glatrus 20mg Injection
By Glatrus
Rx
1ml Injection in a Vial

Composition
Glatiramer Acetate(20mg)

Manufacturer - Taj Pharma India Ltd
first floor, 15-6-108 afzal gunj, hyderabad, telangana 500012

Expires on or after
October, 2025

liver
Limited information is accessible regarding the use of Glatrus 20mg Injection in individuals with liver conditions. It is advised to seek guidance from your healthcare provider regarding the safety and suitability of this medication in such cases.

kidney
Limited information exists regarding the use of Glatrus 20mg Injection in patients with kidney disease. It is recommended to consult your doctor and have regular monitoring of kidney function tests during the treatment.

alcohol
Caution is advised when drinking alcohol while using Glatrus 20mg Injection. Consult your doctor for guidance.

driving
When using Glatrus 20mg Injection, avoid driving if you have symptoms impacting focus and reaction time. It is uncertain if Glatrus 20mg Injection affects driving abilities.

pregnancy
Glatrus 20mg Injection is usually safe for use in pregnancy. Animal studies indicate minimal risks to the baby, but human data is limited.

breastfeeding
During breastfeeding, using Glatrus 20mg Injection is likely safe. Limited data shows no major risks to the baby.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | - |
Action Class | Immunomodulator- Multiple sclerosis (Injectable) |
₹387
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024